Therefore, while definitive genetic evidence using Kim1 mutant mice would be required to prove this hypothesis, our findings suggest that, while additional ameliorating mechanisms maybe involved, the dominant mechanism by which inhibition of PTEC RAR signaling protects against AKI is via the increase of Kim1-dependent efferocytosis. The gene discussed is HAVCR1; the disease is acute kidney injury.